Icagen CEO P. Kay Wagoner: An Interview With "The Pink Sheet" DAILY
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm's leader discusses pipeline and partnership with Pfizer.
You may also be interested in...
Sparks Fly: Pfizer and Icagen Unite To Study Sodium Ion Channels For Pain
Targets in the deal are important in generation of electrical signals in nerve fibers that mediate the initiation and sensation of pain, firms say.
Icagen/J&J Terminate Phase III Sickle Cell Trial
Data monitoring committee advises low probability of achieving crisis reduction endpoint.
Teva Says The Time Is Right For Two Big Immunology Biosimilar Launches
US market access senior VP Tom Rainey talks to Scrip about the upcoming launches of biosimilar versions of Humira and Stelara.